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INTRODUCTION
Directed differentiation of embryonic stem (ES) and induced
pluripotent stem (iPS) cells into endodermal derivatives is intensely
studied for its clinical promise in cell replacement therapies. One
possible target for therapy is type 1 diabetes, a degenerative disease
in which insulin-producing β cells of the pancreas are destroyed by
autoimmune attack (Bach, 1994). The shortage of transplantable β
cells has stimulated much interest in the in vitro generation of β
cells from ES cells (Raikwar and Zavazava, 2009; Zhou and
Melton, 2008). Although numerous approaches have been used to
derive β-like cells, early attempts were lacking in efficiency,
reproducibility, stringency of β cell identification and a thorough
understanding of the origins and identities of the cell types
produced (Blyszczuk et al., 2003; Hansson et al., 2004; Hori et al.,
2002; Lumelsky et al., 2001; Rajagopal et al., 2003; Soria et al.,
2000). This led to efforts aimed at reproducing the sequential steps
that characterize normal β cell ontogenesis. This approach involves
first coaxing ES cells into becoming definitive endoderm (DE),
then providing instruction to become pancreatic in nature.
Pancreatic progenitors are subsequently induced to adopt an
endocrine identity, and, finally, directed towards a stable β cell fate.
Thus, a necessary first step in the directed differentiation of ES
cells towards insulin-producing β cells is the generation of a proper
endodermal cell population that is competent to respond to
subsequent differentiation signals that specify a complete
pancreatic fate.
Our understanding of endoderm formation in vertebrates stems
mainly from studies in Xenopus, zebrafish and mouse (Lewis and
Tam, 2006; Stainier, 2002; Tam et al., 2003; Tian and Meng, 2006).
These studies all point to an essential in vivo role for Nodal, a
member of the transforming growth factor beta (TGFβ) family, in
directing development of the DE (Grapin-Botton and Constam,
2007; Schier, 2003; Stainier, 2002; Zorn and Wells, 2007). Nodal
signaling is activated upon interaction of Nodal ligands with activin
type I and type II serine/threonine kinase receptors [ALK4
(Acvr1b), ActRIIB (Acvr2b), respectively] and the epidermal
growth factor-Cripto-FRL1-Cryptic (EGF-CFC) co-receptor
(Cripto; also known as Tdgf1). Stimulation of the activin receptors
leads to phosphorylation and activation of the downstream
transcriptional effector Smad2, which subsequently interacts with
Smad4 and co-activators (e.g. Foxh1, Xenopus mixer) to regulate
target gene expression. Activin A is a related member of the TGFβ
family that initiates signaling through the same receptors as Nodal
(but without Cripto), eliciting a similar cascade of intracellular
events via SMADs. Activin A is therefore commonly used to
mimic Nodal/Smad signaling in in vitro applications.
Recent work has highlighted significant progress in the
differentiation of mouse and human ES cells into DE (Borowiak et
al., 2009; D’Amour et al., 2005; Kubo et al., 2004; Yasunaga et al.,
2005), pancreatic progenitors (Chen et al., 2009; D’Amour et al.,
2006; Micallef et al., 2005) and insulin-secreting cells (Basford et
al., 2012; D’Amour et al., 2006; Jiang et al., 2007; Micallef et al.,
2012; Nostro et al., 2011; Rezania et al., 2011). Furthermore,
human ES cell-derived pancreatic endoderm has been shown to
protect against hyperglycemia after transplantation into
streptozotocin-treated mice, demonstrating the therapeutic potential
of ES-derived cells (Kroon et al., 2008; Zhang et al., 2009). Despite
these achievements, current protocols remain limited in efficiency
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SUMMARY
Embryonic stem (ES) cells hold great promise with respect to their potential to be differentiated into desired cell types. Of interest
are organs derived from the definitive endoderm, such as the pancreas and liver, and animal studies have revealed an essential role
for Nodal in development of the definitive endoderm. Activin A is a related TGF member that acts through many of the same
downstream signaling effectors as Nodal and is thought to mimic Nodal activity. Detailed characterization of ES cell-derived
endodermal cell types by gene expression analysis in vitro and functional analysis in vivo reveal that, despite their similarity in gene
expression, Nodal and Activin-derived endodermal cells exhibit a distinct difference in functional competence following
transplantation into the developing mouse embryo. Pdx1-expressing cells arising from the respective endoderm populations exhibit
extended differences in their competence to mature into insulin/c-peptide-expressing cells in vivo. Our findings underscore the
importance of functional cell-type evaluation during stepwise differentiation of stem cells.
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of β cell output, understanding of cell type maturity, and definition
of conditions required for the complete derivation of bona fide,
stable β cells in vitro. Furthermore, functional evaluation of cells
at key developmental nodes during differentiation has largely been
lacking. For measurable progress in the creation of pancreatic β
cells that can be reliably used in research and therapy, we believe
that stepwise validation of cell identity, including functional tests,
would represent a significant advance.
We evaluated murine endoderm populations generated by
treatment with recombinant Nodal and Activin proteins. We report
here that, despite expressing cardinal markers of endoderm and
being nearly identical at the level of global transcription, Nodal and
Activin-derived mouse DE cells exhibit a striking difference in
functional competence upon transplantation into the gut endoderm
of the mouse embryo. Nodal- but not Activin-derived endoderm
can efficiently contribute to the embryonic endoderm, differentiate
into endoderm derivatives, and form primitive gut tubules upon
ectopic injection. These endoderm differences impact the
subsequent development of pancreatic progenitors in vitro as well
as their competency to form clusters of insulin/c-peptide-expressing
cells in vivo. This work advances our understanding of endodermal
and pancreatic identities generated from ES cells in vitro and
provides a grounded basis for differentiating pluripotent stem cells
into functional β cells for disease modeling and cell therapy.
MATERIALS AND METHODS
Mouse ES cell culture and differentiation
Mouse ES cells (mESCs) were maintained on gelatin-coated plates with
mouse embryonic fibroblasts (MEFs) in mESC medium: Dulbecco’s
Modified Eagle Medium (DMEM; Invitrogen), 0.1 mM non-essential
amino acids (NEAA; Invitrogen), 1 Glutamax, 1 penicillin-
streptomycin (Penn/Strep; Invitrogen), 15% fetal bovine serum (FBS;
HyClone), 0.055 mM -mercaptoethanol (Me; Sigma) and 5105 units
leukemia inhibitory factor (LIF; Chemicon).
For differentiation, cultures were MEF-depleted and seeded in mESC
medium at ~2700 cells/cm2 on gelatin-coated dishes. Endoderm
differentiation was induced the following day for 6-8 days in DMEM, 5%
FBS, 0.1 mM NEAA, 1 Glutamax, 1 Penn/Strep, 0.055 mM Me, or
in advanced RPMI medium (Invitrogen), 0.2-0.5% FBS, 1 Glutamax and
1 Penn/Strep, with 50 ng/ml recombinant human Activin A or 1000
ng/ml recombinant mouse Nodal (R&D Systems); media changed every
other day. Pancreatic differentiation was carried out as described (Borowiak
et al., 2009).
Preparation of mouse embryos for injection
CD1 males were crossed with ICR females (Charles River, Jackson Labs),
with noon of the day of plug identified as embryonic day (E) 0.5. On the
day before injection, E8.5 embryos were isolated from the uterus and
decidua. Reichart’s membrane and parietal endoderm were removed and
trimmed at the base of the ectoplacental cone, leaving the yolk sac and
amnion undamaged and intact to support ex vivo development. Embryos
were cultured overnight in low-attachment 6-well dishes (Corning) in pre-
warmed 50% advanced DMEM/F12 (Invitrogen), 50% heat-inactivated,
sterile-filtered rat serum (Valley Biomedical) and 1 Penn/Strep (total
volume 2 ml per embryo) in a humidified incubator (5% CO2/20% O2/75%
N2). The slight developmental delay provided by static culture of E8.5 mice
enabled capture of E8.75-9.0 partially turned embryos, used the following
morning for cell injection.
Embryo injection and whole embryo ex vivo culture
Donor cells were harvested at the single-cell level and resuspended in
embryo culture media at ~50,000-100,000 cells/µl. Resuspended cells were
delivered to the primitive gut tube of E8.75 mice by injecting the anterior
and posterior intestinal portals and the exposed gut lumen using pulled
capillaries [50-75 µm VWR (ID)] via mouth pipette. Following injection
of ~100,000-150,000 cells, embryos were cultured in fresh embryo culture
medium for 24-30 hours in a humidified roller bottle culture unit (BTC
Engineering) at 37°C (5% CO2/20% O2/75% N2).
Flow cytometry
Differentiated cells were harvested and resuspended in PBS/5% FBS and
sorted for ES-derived endoderm and pancreatic lineages by flow cytometry
using FACSAria (Becton Dickinson) or MoFlo (Dako Cytomation).
Following sorting, cells were centrifuged and resuspended in minimal
volume for embryo or kidney capsule injection, RT-PCR or microarray
analyses.
Global gene expression analysis by microarray
Sox17-GFP(+) cells were sorted from Nodal- or Activin-treated mESC
cultures. Total RNA isolated using Qiashredder and RNAeasy Mini Kit
(Qiagen). Biotinylated cRNA was prepared from ≥100 ng of RNA using
Illumina TotalPrep RNA Amplification Kit (Ambion) and hybridized to
Illumina Mouse Genome Bead Chips (MouseRef8). Samples were
prepared as biological duplicates. Data were acquired with Illumina
Beadstation 500 and evaluated using BeadStudio Data Analysis Software.
Full data are available in Gene Expression Omnibus (GEO) database under
accession number GSE41086.
Immunofluorescence
Cultures were fixed with fresh 4% paraformaldehyde/PBS, washed in 0.1%
Triton-X in PBS (0.1% PBT) then blocked in 5% donkey serum (Jackson
ImmunoResearch) in 0.1% PBT. Primary antibody was applied in 5%
donkey serum in 0.1% PBT overnight at 4°C. Next day, cells were washed
three times, secondary antibody was applied for 1 hour at room temperature
and counterstained with DAPI (Sigma). Images captured with an Olympus
IX70 microscope.
Cultured embryos were fixed with fresh 4% paraformaldehyde/PBS
overnight at 4°C. Embryos were washed twice in PBS on a Nutator (TCS
Scientific Corporation), equilibrated in 30% sucrose/PBS overnight,
followed by equilibration in 1:1 of 30% sucrose/PBS and OCT (Tissue
Tek), and then cryo-embedded in OCT. Samples were sectioned at 14 m
onto Superfrost slides (VWR). Tissue sections were rehydrated in PBS,
washed in 0.1% PBT, briefly permeabilized in 0.5% PBT then washed in
0.1% PBT. Primary and secondary antibodies were applied as described
above. Slides were coverslipped using Fluoromout G (Southern Biotech).
Primary antibodies were: goat anti-SOX17 (R&D Systems), goat anti-
HNF3/FOXA2 (M-20), goat anti-CLDN6 (C-20), goat anti-SOX7 (E-20),
rabbit anti-DAB2 (H-110), rabbit anti-SPARC (H-90), goat anti-SOX2 (Y-
17) (all Santa Cruz), goat anti-PDX1 (provided by C. Wright, Vanderbilt
University Medical Center, TN, USA), rabbit anti-LAM (Sigma), rabbit
anti-PROX1 (Covance), mouse anti-CDX2 (Biogenex), guinea pig anti-
insulin (DAKO), rabbit anti-c-peptide (Linco/Millipore), rabbit anti-
RFP/DsRed (MBL), chicken anti-GFP (Aves Labs), Alexa488-conjugated
rabbit anti-GFP (Invitrogen). Secondary antibodies were: Alexa488- or
594-conjugated donkey anti-rabbit; Alexa488-, 594- or 647-conjugated
donkey anti-goat; Alexa488-conjugated donkey anti-mouse, Alexa488-
conjugated goat anti-chicken (Invitrogen), FITC-conjugated donkey anti-
chicken (all Jackson Laboratories). Nuclei were visualized with DAPI
(Sigma).
Semi-quantitative and real-time quantitative PCR
For semi-quantitative PCR, total RNA from ES and differentiated cells was
isolated with RNAzol (Sigma). cDNA synthesis was carried out using 0.2
g random hexamer primer (Pharmacia Biotech), 1 first strand reaction
buffer (Invitrogen), 0.5 mM deoxyribonucleotide triphosphates (dNTPs;
Denville Scientific), 0.01 mM dithiothreitol (DTT; Invitrogen), 20 units
RNasin (Promega), 200 units M-MLV reverse transcriptase (Invitrogen) in
30 µl total reaction mixture, for 1.5 hours at 37°C. Gene expression was
analyzed by template cDNA PCR (25-30 cycles). PCR products were
resolved on 2% agarose gels, visualized by ethidium bromide staining and
images were captured via AlphaImager 3400 (Alpha Innotech). For
quantitative PCR, total RNA was isolated using Trizol (Invitrogen).
Reverse transcription was performed using Superscript III and PCR using
SYBR Green (Invitrogen) and a MX3000p light cycler (Stratagene) (≤45
cycles). Expression values were normalized to -actin.
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Kidney capsule injections of pancreatic progenitors
Pdx1-GFP(+) cells purified by FACS, collected in DMEM in 5% FBS,
centrifuged and resuspended in minimal volume. SCID-Beige males (6-10
weeks of age) were anesthetized with Avertin (250 mg/kg; Sigma), shaved
at the surgical site and cleaned with isopropanol, and iodine. The left
kidney was exposed and 0.5106 cells were injected via micropipette into
the upper kidney pole followed by low temperature cautery, return to
original anatomical position and closure of muscle with continuous sutures
and skin with wound clips. Six weeks later, transplants were recovered,
fixed and processed for cryosectioning and immunostaining. Images were
captured with a Zeiss LSM510 Meta confocal microscope. Quantification
of C-peptide(+) cells was performed on six animals per group, 15 images
per animal, ≥1000 cells counted per condition.
RESULTS
Nodal and Activin A promote the differentiation
of highly similar definitive endoderm profiles 
in vitro
Although some reports have included brief mention of Nodal in the
induction of mesendoderm (Tada et al., 2005) and endoderm
(Hansson et al., 2009), current protocols for differentiating ES cells
into endoderm have predominantly involved the use of Activin A
(D’Amour et al., 2005; Gadue et al., 2006; Kubo et al., 2004;
Yasunaga et al., 2005; Nostro et al., 2011). Nodal, however, is an
essential signal during vertebrate gastrulation and specification of
the DE (Ding et al., 1998; Lowe et al., 2001; Vincent et al., 2003).
As Activin and Nodal signaling are similar, but not identical, we
compared the capacity of Activin and Nodal in directing the
differentiation of ES cells into genuine DE cells.
Prior to differentiation, wild-type AV3 mouse ES cells (mESCs)
were depleted of mouse embryonic fibroblast (MEF) feeders and
plated onto gelatin-coated dishes at low density for overnight
attachment in mESC medium. The next day, differentiation was
induced by switching to reduced serum conditions containing no
growth factor (untreated control), or 40, 200 or 1000 ng/ml
recombinant Nodal, or 10, 50, 100 or 200 ng/ml recombinant
Activin A. Following 7 days of differentiation, expression of the
pan-endodermal proteins Sox17 (Kanai-Azuma et al., 2002) and
Foxa2 (Ang et al., 1993; Monaghan et al., 1993; Sasaki and Hogan,
1993) was assessed by immunofluorescence and quantification.
Consistent with previous reports, we found that both Nodal and
Activin induced robust endoderm differentiation, in contrast to
untreated controls (supplementary material Fig. S1A). We observed
optimal induction of 79±6.2% (mean±s.e.m.) Sox17(+) cells with
1000 ng/ml Nodal and 65.3±9.8% Sox17(+) cells with 50 ng/ml
Activin, compared with 15.2±2.8% Sox17(+) cells in controls
(supplementary material Fig. S1B). Quantification of cells co-
expressing Foxa2 revealed a similar trend across dosage
concentrations, with the majority of Sox17(+) cells also expressing
Foxa2 (supplementary material Fig. S1A,B). Time-course
experiments revealed that peak endoderm output occurred between
6 and 8 days of differentiation with minimal variation in between
(data not shown). Therefore, for subsequent studies Nodal and
Activin A were used at 1000 ng/ml and 50 ng/ml, respectively, for
~1 week.
Next, we characterized the proliferation rate of cells
differentiated with Activin A and Nodal across time. mESCs were
plated at the same density and the total cell number was compared
at 2, 4 and 6 days following endoderm induction. Nodal- and
Activin-treated cells appeared similarly healthy during culture and
proliferated comparably over the duration of differentiation, even
when challenged with different cell-seeding densities and serum
concentrations (supplementary material Fig. S1C).
Although Sox17 and Foxa2 are required for DE development
(Ang et al., 1993; Kanai-Azuma et al., 2002), both genes are also
expressed in the extra-embryonic endoderm (ExEn). To date, no
unique markers exist for DE, although markers for ExEn are well
defined. ExEn cells can therefore be distinguished by their
expression of both pan-endoderm and ExEn markers, whereas DE
cells can be distinguished by their expression of pan-endoderm
markers and lack of ExEn markers. To examine whether Nodal and
Activin favor induction of DE or ExEn, we characterized the co-
expression of endoderm and ExEn markers using a combination of
immunocytochemistry, RT-PCR and quantitative real-time PCR of
purified endoderm.
Immunofluorescence analysis showed that neither Nodal- nor
Activin-induced endoderm expresses significant levels of the ExEn
markers Dab2 (Morrisey et al., 2000), Sparc (Mason et al., 1986),
LAMα1 (Lama1 – Mouse Genome Informatics) (Thomas and
Dziadek, 1993) and Sox7 (Kanai-Azuma et al., 2002)
(supplementary material Fig. S1D). These results contrast with
observations in spontaneously differentiated cultures, or cultures
treated with retinoic acid (supplementary material Fig. S1D), in
which ExEn cells were readily detectable by immunofluorescence
and distinct morphology (flattened cells with a high cytoplasmic-
to-nuclear ratio). RT-PCR analysis of RNA isolated from ES-
derived endoderm also showed that although Sox17 and Foxa2 are
induced by Nodal and Activin, there is minimal to no expression
of the ExEn markers tPA (Plat – Mouse Genome Informatics)
(Strickland et al., 1976), Hnf4a (Chen et al., 1994), Ttr (Abe et al.,
1996), Amn (Tomihara-Newberger et al., 1998), Pem (Rhox5 –
Mouse Genome Informatics) (Lin et al., 1994), Lama1 and Sox7
(supplementary material Fig. S1E).
For quantitative analysis of gene expression, we utilized a
Sox17-DsRed mESC line, containing a fluorescent DsRed
reporter driven by the Sox17 promoter (Borowiak et al., 2009).
DsRed(+) endodermal cells were purified by flow cytometry
following induction by Nodal and Activin. We then harvested
RNA from these cells and assessed the expression of additional
ExEn markers [Afp, Amn, Cldn2, Hnf4a, Npas2, Tcf2 (Hnf1b –
Mouse Genome Informatics)] (Sherwood et al., 2007) by
quantitative RT-PCR. The gene expression profiles of both
Nodal- and Activin-derived endoderm more closely resembled
DE than ExEn dissected from E8.25 mice (supplementary
material Fig. S1F). Together, these results confirm and extend
previous findings on Activin (D’Amour et al., 2005; Tada et al.,
2005; Yasunaga et al., 2005) to include Nodal, in that both TGFβ
family members preferentially induce DE rather than ExEn in
vitro, and that this induction occurs with approximately equal
effectiveness.
A functional assay for in vitro-derived endoderm
To examine whether ES cell-derived endoderm is functionally
equivalent to its embryonic counterpart in vivo, we developed a
functional assay based on transplantation of ES-derived cells into
the mouse embryo for whole embryo ex vivo culture. We took
advantage of the accessibility of the early embryonic endoderm
during gut tube formation (Fig. 1A) (Wells and Melton, 1999). At
the completion of gastrulation (E7.5), the embryonic DE comprises
a sheet of cells that begins to roll onto itself during gut tube
morphogenesis. As rolling initiates, the anterior and posterior ends
seal from the outer ends towards the center, forming the anterior
and posterior (A/P) intestinal portals (E8.5). Closure of the gut
tube, in combination with embryonic turning, results in formation
of the primitive gut tube at E9.0. Organ domains then bud and
677RESEARCH ARTICLENodal versus Activin-derived endoderm
D
E
V
E
LO
P
M
E
N
T
678
differentiate to form endodermal derivatives, such as the lung,
stomach, liver, pancreas and intestine (E10.5).
To address whether in vitro-derived endoderm is comparable in
identity and function to embryonic endoderm, we deposited ES-
derived endoderm into the nascent gut lumen of E8.75 embryos,
prior to closure. To track donor ES-derived endoderm cells in host
embryos following transplantation, fluorescently labeled mESCs
were differentiated with either Nodal or Activin for 7 days, then
injected into the developing gut endoderm of unlabeled E8.75 mice
(Fig. 1B) for ex vivo culture. Embryos were cultured with their yolk
sacs intact, as we have found that this aids embryonic development
ex vivo. Over the course of ex vivo culture (24-30 hours), the
embryonic gut tube closes, the embryo completes turning, and
significant development occurs concomitant with organogenesis
(Fig. 1C). Embryos were then harvested at ~E10.25 (supplementary
material Movie 1) to assess the fate of injected cells.
Endoderm generated by Nodal and Activin are
functionally distinct ex vivo
We began our functional studies by injecting endoderm
differentiated from a ubiquitously fluorescent mESC line (Actb-
EYFP; Fig. 2A), in which enhanced yellow fluorescent protein is
driven by the β-actin promoter (Hadjantonakis et al., 2002). We
found that Nodal-induced endoderm contributed to the host gut
endoderm with high incidence by efficiently engrafting into the
embryonic gut tube in 57.8±3.4% of injected embryos (n=96;
Fig. 2B, top). Furthermore, these cells adopted the morphological
characteristics of gut epithelial cells and expressed the gut
endoderm markers Foxa2 and Cldn6 (Anderson et al., 2008),
similar to host endoderm. By contrast, Activin-induced cells
contributed to endoderm at a much lower incidence, with only
11.6±1.2% of injected embryos exhibiting weak engraftment
(n=92). The majority of injected cells failed to integrate, and
instead remained loosely clustered within the gut lumen along the
A/P axis (Fig. 2B, bottom). No improvement was observed in the
engraftment potential of Activin-induced cells even when
differentiation was extended to 9-10 days, or upon combined
culture with Wnt3a (data not shown).
These functional differences were unexpected given the in vitro
similarity of endoderm gene expression in Nodal- and Activin-
induced endoderm (supplementary material Fig. S1). Possible
causes for these differences include non-specific effects from either
cell culture conditions or the presence of other cell types in the
injected population that could contribute to the contrasting
phenotypes. For example, if Activin A is intrinsically toxic, cells
treated with Activin A might be unhealthy and compromised in
function compared with Nodal-differentiated cells. However, this
is inconsistent with the observation that Nodal- and Activin-
induced endoderm cells show similar growth kinetics
(supplementary material Fig. S1C). Alternatively, non-endodermal
cell types present in the heterogeneous injected population might
hamper the ability of Activin-induced endoderm to interact with
endogenous endoderm. We therefore injected purified endoderm
following differentiation and cell sorting of a Sox17-GFP mESC
line (Kim et al., 2007). To track the fate of Sox17-GFP-
differentiated endoderm following downregulation of Sox17 during
normal maturation of the embryonic gut endoderm, we further
labeled these cells by transduction with a lentivirus carrying DsRed
under the control of the Ubiquitin promoter (Sox17-GFP/Ub-
DsRed) (Niakan et al., 2010). Following differentiation with Nodal
or Activin A, we selected for GFP-DsRed double-positive cells
such that endoderm could be purified (GFP), then tracked long-
term (DsRed) after injection into the embryo (Fig. 2C). Injection
of purified GFP(+)/DsRed(+) endoderm (Fig. 2D) confirmed
previous observations (Fig. 2B). Nodal-derived endoderm readily
contributed to the host gut tube, as revealed by epithelialized
DsRed-marked cells within the gut tube, which co-expressed Foxa2
(n=8/8; Fig. 2D, top). Despite injection of an equal number of
Activin-derived endoderm, these cells still largely failed to
contribute to the host gut tube. In the best cases, we observed only
RESEARCH ARTICLE Development 140 (3)
Fig. 1. A functional assay for ES cell-derived endoderm. (A) Schematic of DE development in the mouse embryo. ES cell-derived endoderm is
injected into the embryonic gut lumen prior to closure (E8.75). (B) Partially turned E8.75 embryo within the yolk sac (ys) following delivery of YFP-
labeled ES-derived endoderm into the gut lumen (arrowhead). (C) E10.25 embryo following 24-30 hours of ex vivo culture and removal from the
yolk sac. Dotted lines indicate embryonic gut tube containing transplanted cells. epc, ectoplacental cone; mb, midbrain; flb, forelimb bud. A,
anterior; AIP, anterior intestinal portal; CIP, caudal intestinal portal; D, dorsal; Int, intestine; Li, liver; Lu, lung; P, posterior; St, stomach; V, ventral.
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a small degree of contribution in both the number of cells per
embryo as well in the total number of embryos (n=4/18; Fig. 2D,
bottom). Figure 2D illustrates the integration of ~40-50 Nodal-
derived endodermal cells compared with five to six Activin-derived
endodermal cells per plane of section. The majority of Activin-
derived endodermal cells were found scattered and unincorporated
within the gut lumen. These results exclude indirect effects from
non-endodermal cells within the injected population and suggest
that Nodal- and Activin-differentiated endoderm differ at a
fundamental level in their developmental potential.
As a further functional test, we investigated the tissue specificity
of Nodal-derived endoderm with respect to contributions to the
host embryo. We injected Nodal-differentiated Actb-EYFP cells
into an alternative lumenal structure, the neural tube. In contrast to
its behavior when injected into the gut tube, Nodal-induced
endoderm does not engraft into the neural tube (Fig. 2E, top),
remaining instead as a distinct cluster within the neural lumen. The
cells do, however, retain expression of Sox17, suggesting their
commitment to the endoderm fate. Interestingly, Nodal-derived
Sox17(+) cells often formed independent primitive gut tube-like
structures despite residing in ectodermal tissue fated to become
brain and spinal cord. Activin-induced endoderm also did not
engraft (Fig. 2E, bottom); however, unlike Nodal-induced
endoderm, these cells rarely gave rise to organized structures.
These results support the contention that contribution of Nodal-
derived endoderm to the embryonic gut tube is tissue specific.
679RESEARCH ARTICLENodal versus Activin-derived endoderm
Fig. 2. Nodal- but not Activin-derived endoderm efficiently contributes to the embryonic endoderm upon transplantation into the
mouse embryo. (A) Differentiation scheme of Actb-EYFP mESCs for functional analysis. d, days of differentiation. (B) Immunofluorescence (IF)
analysis of sections of embryos injected with Nodal- or Activin-differentiated Actb-EYFP cells. Foxa2 and Cldn6 mark gut endoderm; YFP marks ES-
derived cells, DAPI marks nuclei. Insets: magnified views of engrafted Actb-EYFP endoderm. (C) Differentiation scheme and purification of Sox17-
GFP/Ub-DsRed mESCs for functional analysis. (D) IF analysis of sections of embryos injected with purified Nodal- or Activin-differentiated Sox17-
GFP(+)/Ub-DsRed(+) cells. (E) IF analysis of sections of embryos in which the neural tube (nt) was injected with Nodal- or Activin-differentiated Actb-
EYFP cells. (F) IF analysis of sections of embryos injected with mESCs (Actb-EYFP, Oct4+), ExEn cells (XEN-GFP, Dab2+) or ES-derived motor neurons
(HB9-GFP).
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Conversely, to examine whether contribution of donor cells to
the gut tube is cell specific, we tested the behavior of other cell
types by injecting them into the embryonic gut tube. We used three
different kinds of cells: undifferentiated Actb-EYFP cells, ExEn
cells derived from mouse blastocysts (XEN) (Kunath et al., 2005),
and an alternative ES-derived cell type, motor neurons. Upon
injection, all three cell types failed to incorporate into the
endogenous endoderm, remaining instead as separate cell clusters
within the gut lumen (Fig. 2F). These findings demonstrate that the
contribution of donor cells to the gut tube is cell specific and that
the ability to efficiently engraft into the host endoderm is specific
to Nodal-derived endoderm.
The capability of Nodal-derived endoderm to incorporate into
endogenous endoderm (Fig. 2B,D) led us to investigate whether
these cells could continue to mature in vivo and undergo organ
specification. Immunofluorescent confocal analysis of sectioned
embryos following extended embryo culture (30 hours) showed
that Nodal-differentiated Actb-EYFP cells residing in the gut
endoderm appropriately upregulate marker genes for organ
domains including the lung (Sox2), liver (Prox1), pancreas (Pdx1)
and intestine (Cdx2) (Fig. 3A). Magnified optical sections (1.5 m)
confirmed co-expression of these transcription factors in the
nucleus of YFP(+) donor cells (Fig. 3A, insets). Expression of
these genes occurred in proper regions along the embryonic axis,
with no aberrant expression observed outside the respective organ
domains. For example, YFP(+) ES-derived cells only expressed
Pdx1 within the A/P regions of the embryo where endogenous
Pdx1 could be found, despite engraftment of cells along the length
of the embryo. We also note that prior to injection very few cells
in the differentiating population expressed Sox2 and Cdx2 (<1-
2%), and no cells expressed Pdx1 and Prox1 (data not shown).
These data demonstrate that Nodal-derived endoderm can continue
development and mature in vivo, contributing appropriately to
major organ domains along the embryonic A/P axis.
As an additional functional test of ES-derived endoderm, we
examined the cell autonomy of Nodal- and Activin-induced Actb-
EYFP cells by injecting them into ectopic regions of the embryo,
such as the trunk mesenchyme. We found that 66.7% (n=48) of
embryos injected with Nodal-induced endoderm exhibited formation
of ectopic gut tube-like structures (Fig. 3B, top). These tubular
structures were positive for both Foxa2 and Cldn6, and measured
~100-150 m in length. By contrast, embryos injected with Activin-
induced endoderm exhibited substantially less tubule-forming
capacity (7.6%, n=46), with cells appearing mainly scattered and
RESEARCH ARTICLE Development 140 (3)
Fig. 3. Endoderm generated by Nodal and Activin are functionally distinct. (A) Engrafted Nodal-induced endoderm undergoes organ-
specification within the embryonic gut tube. Immunofluorescent (IF) confocal analysis of sections of mouse embryos (1.5 m) following injection of
Nodal-differentiated Actb-EYFP into the gut lumen and 30 hours of culture. YFP marks Nodal-induced endoderm; Sox2 marks organs anterior
to/including lung; Prox1 marks liver; Pdx1 marks pancreas; Cdx2 marks intestine. Insets: magnification of nuclear marker expression within EYFP(+)
donor cells. (B) Nodal- but not Activin-induced endoderm forms ectopic primitive gut tubules. IF analysis of sections of embryos following injection
of Actb-EYFP-derived endoderm into the trunk mesenchyme and 24 hours of culture. Arrowheads indicate ectopic gut tubule adjacent to
endogenous gut tube; brackets indicate disorganized cells at injection site. Foxa2 and Cldn6 mark endoderm; DAPI marks nuclei. (C) Functional
capacity of in vitro differentiated endoderm varies based on timing, exposure to Nodal or Activin. Left: outline of mESC exposure (sequentially or in
parallel) to Nodal (N) versus Activin (A) over time. Endoderm induction occurred on day zero, cells were injected on d8. Right: percentage of
embryos exhibiting gut endoderm contribution following injection of respective endoderm populations. Data represented as mean± s.e.m.
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disorganized at the site of injection (Fig. 3B, bottom). These results,
together with injections into the neural tube (Fig. 2E), demonstrate
that even in non-native environments such as the mesoderm or
ectoderm, Nodal-differentiated cells retain their endoderm identity
and autonomously organize into primitive gut tubes.
Given the contrasting phenotypes of Nodal- and Activin-induced
endoderm, we investigated next whether either factor exerts a
dominant effect when applied in sequence or in tandem. We
characterized how the exposure and timing of Nodal versus Activin
A application would affect the functional capability of the resulting
ES-derived endoderm. Sox17-GFP/Ub-DsRed mESCs were treated
with Nodal and Activin A serially (Nodal then Activin A, or vice
versa) or simultaneously, then sorted for GFP(+)/DsRed(+)
endoderm and functionally tested by injection into the embryonic
gut tube (Fig. 3C).
When cells were first treated with Nodal (days 0-4), then
switched to Activin A for the remainder of differentiation (days 4-
8), the percentage of embryos exhibiting gut contribution was
similar to those which received fully Activin-differentiated
endoderm (days 0-8) (14.1±3.1% versus 11.6±1.2%, respectively).
This was a marked difference given that 57.8±3.4% of embryos
exhibit gut contribution when injected with fully Nodal-
differentiated endoderm (days 0-8), compared with only 14.1±3.1%
of embryos when Nodal is replaced with Activin A for the second
half of differentiation. Conversely, when cells initially exposed to
Activin A (days 0-4) were then switched to Nodal (days 4-8), there
was rescue of the Activin A phenotype and cells gained the ability
to engraft in the embryonic gut tube at much higher levels
(42.1±10.9%). Finally, when Nodal and Activin A were
simultaneously applied throughout the duration of differentiation
(days 0-8), Nodal effects dominated, and the cells were as capable
of contributing to the host gut endoderm as those that were
differentiated with Nodal alone (53±13.6% versus 57.8±3.4%,
respectively).
These data indicate that Activin A treatment (in part or in full)
is insufficient to direct proper differentiation of functionally
competent endoderm. Nodal-derived endoderm more closely
resembles endogenous endoderm in its ability to identify with and
engage in gut tube morphogenesis in vivo. More importantly, the
observation that Activin-derived endoderm can transition from a
functionally incompetent state to a competent state upon additional
treatment with Nodal suggests that the two endodermal populations
represent related but distinct states of cell potential.
Gene expression profiling of Nodal- and Activin-
derived endoderm
To explore the molecular basis of these functional differences, we
purified Nodal- and Activin-derived endoderm and compared their
gene expression profiles. Sox17-GFP cells were differentiated in
the presence of Nodal or Activin for 7 days, after which GFP(+)
cells were purified by FACS. Undifferentiated ES cells were also
included for comparison as a control. RNA was isolated from these
cells for transcriptional analysis by Illumina microarray profiling
(Fig. 4A). Scatter plot analysis showed that both Nodal- and
Activin-derived endoderm are distinct from undifferentiated
mESCs. The r2 value (square of linear correlation coefficient)
between ES cells and Activin-derived endoderm was 0.8352
(Fig. 4B). Similarly, the r2 value between ES cells and Nodal-
derived endoderm was 0.8495 (Fig. 4C). As expected,
undifferentiated ES cells expressed high levels of the pluripotent
markers Oct4 (Pou5f1 – Mouse Genome Informatics), Sox2 and
Nanog, whereas ES-derived endoderm expressed high levels of
endoderm markers, Sox17, Foxa2 and Cldn6. When compared
against one another, we found that Nodal- and Activin-derived
endoderm were highly similar in transcriptional profile (Fig. 4D),
with an r2 value of 0.9937. These results indicate that Nodal- and
Activin-derived endoderm are nearly identical in terms of gene
expression at the level of global transcription.
Next, we specifically examined the effect of Nodal and Activin
on expression levels of genes that typically impact morphogenesis
or engraftment, including those involved in cell adhesion, cell
attachment and cell migration. No marked differences were
observed in the expression of classical cell adhesion factors
(cadherins), cell attachment factors (integrins, Icams, Vcam1,
Pecam1) or extracellular matrix degrading enzymes that aid in cell
migration (matrix metalloproteinases) (Fig. 4E).
Although the two endodermal populations are very similar in
global transcription, we questioned whether there might be subtle
differences. Among genes differentially expressed at 1.6-fold or
greater (P≤0.05), Nodal-derived endoderm exhibited upregulation
of multiple genes involved in either development, maintenance or
function of endodermal organs and their cellular derivatives
(Fig. 4F). These include Sst, Ghrl, Hnf4a, Ly64 (Muc13 – Mouse
Genome Informatics), Ednrb, Pcbd (Pcbd1 – Mouse Genome
Informatics), Tmprss2, Pyy, Tbx3, Ctsh and Pygl. Activin-derived
endoderm lacked upregulation of these genes, instead exhibiting
upregulation of key genes expressed in primitive-streak stage
embryos, namely, T and Mixl1. These data suggest that both
populations are in the endoderm lineage, sharing expression of
Sox17, but the molecular identity of the Activin-derived endoderm
more closely resembles mesendoderm or nascent endoderm during
or shortly after gastrulation, whereas Nodal-derived endoderm
more closely resembles endoderm undergoing gut tube
morphogenesis and organ-specific differentiation. These results
suggest that Nodal- and Activin-derived cells are related in lineage
but differ in degree of endoderm progression.
Nodal- and Activin-derived endoderm differ in
pancreatic potential
To explore how ‘poised’ these cells were for downstream
differentiation in vitro, we examined the developmental
competence of ES cell-derived endoderm to undergo subsequent
pancreatic specification. Following 6 days of endoderm
differentiation with either Nodal or Activin A, culture conditions
were switched to promote pancreatic differentiation (Borowiak et
al., 2009; Chen et al., 2009; D’Amour et al., 2006). The timing and
output of Pdx1, a protein encoded by a gene essential for pancreatic
development (Jonsson et al., 1994; Offield et al., 1996), was then
analyzed by immunofluorescence and quantified every two days to
track the course of pancreatic induction.
Notably, Pdx1 protein expression was detectable earlier in
Nodal- versus Activin-induced endoderm (Fig. 5A). Pdx1(+) cells
were detected as early as day 8 (2 days following pancreatic
induction) in Nodal-treated cells (5.8±1.2%), in contrast to Activin-
treated cells (1.4±0.7%), which did not yet exhibit Pdx1 expression
levels above untreated controls (1.5±0.7%). On day 10 (4 days
following pancreatic induction), Activin-treated cells exhibited
more significant levels of Pdx1 induction (6.2±1.3%), although still
well below levels observed in Nodal-treated cells (19±3.3%). From
this point on, Pdx1 expression continued to increase steadily in
both populations, peaking between days 12 and 14, with the overall
percentage of Pdx1(+) cells remaining moderately higher in Nodal-
treated cells (Nodal: 42.9±1.2%, Activin A: 30.6±6.2%, day 12).
Untreated controls exhibited minimal spontaneous activation of
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Pdx1 expression (2.4±0.2%, day 12). These data suggest that
Nodal- and Activin-induced endoderm differ in their propensity to
undergo pancreatic differentiation. The temporal delay of Pdx1
induction in Activin- versus Nodal-induced endoderm indicates
that the developmental state of the cells is not equal at the onset of
pancreatic induction from endoderm. We observed similar
differences upon liver differentiation from Activin- versus Nodal-
induced endoderm. Nodal-derived endoderm also exhibited greater
competency to undergo differentiation into alpha fetoprotein(+) and
albumin(+) liver progenitors (supplementary material Fig. S2; data
not shown).
Interestingly, we routinely observed two types of Pdx1-
expressing cells: those that expressed high levels of Pdx1
(PDXhigh) and those that expressed low levels (PDXlow). In
particular, the majority of pancreatic progenitors derived from
Activin-induced endoderm were PDXlow, whereas those derived
from Nodal-induced endoderm consistently exhibited an
increased population of PDXhigh cells (Fig. 5B). Parallel
experiments with human ES cell cultures also exhibited the same
phenomena of comparable percentage endoderm induction but
differential output of Pdx1 expression levels (supplementary
material Fig. S3). To characterize the pancreatic progenitor
populations generated from Nodal- and Activin-derived
endoderm, we quantified PDXhigh and PDXlow cells by flow
cytometry following directed differentiation of a mESC line
carrying a GFP reporter under control of the Pdx1 promoter
(Borowiak et al., 2009; Holland et al., 2006). Indeed, PDXhigh and
PDXlow cells were readily detected in both Nodal- and Activin-
induced endoderm (day 12; Fig. 5C). However, although the total
number of Pdx1(+) cells was comparable, the ratio of PDXhigh to
RESEARCH ARTICLE Development 140 (3)
Fig. 4. Gene expression profiling of Nodal- and Activin-derived endoderm. (A) Differentiation and purification scheme of Sox17-GFP mouse
ES cells for gene expression analysis. (B-D) Scatter plots comparing global gene expression of mESCs versus GFP(+) endoderm from Activin (B) or
Nodal (C) treatment, or directly comparing Activin versus Nodal-derived GFP(+) endoderm (D). Center line indicates equivalent levels in gene
expression; two flanking lines indicate twofold difference. (E,F) Relative gene expression (y-axis), plotted as ratio of Nodal divided by Activin signal
(N/A, blue) or Activin divided by Nodal (A/N, red). (E) Expression of genes involved in cell adhesion [E-cad (Cdh1), N-cad (Cdh2), Cdh17, Cdh4],
attachment (Itga1, Itgb1, Icam1, Icam2, Icam4, Icam5, Vcam1, Pcam1) and migration (Mmp2, Mmp11, Mmp14, Mmp15, Mmp16, Mmp17,
Mmp19, Mmp23, Mmp24). (F) Expression of pan endoderm genes (Sox17, Foxa2, Cldn6); primitive streak and mesendoderm genes (T, Mixl); and
genes involved in development, maintenance or function of endodermal organs and their cellular derivatives (Sst, Ghrl, Hnf4a, Muc13, Ednrb,
Pcbd1, Tmprss2, Pyy, Tbx3, Ctsh, Pygl).
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PDXlow cells differed between samples initially exposed to Nodal
versus those exposed to Activin A. Specifically, we found that
Nodal-induced endoderm led to 14% PDXhigh cells, compared
with only 3% PDXhigh for Activin-induced endoderm (Fig. 5D).
To address whether the levels of Pdx1 expression functionally
affect or indicate developmental competence, we purified PDXhigh
and PDXlow populations and transplanted them into the kidney
capsules of adult mice to assess their potential in vivo (Fig. 5E). After
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Fig. 5. Nodal- and Activin-derived endoderm differ in pancreatic potential. (A) Characterization of Pdx1 induction over time. AV3 mESCs
either untreated or treated with Nodal or Activin for 6 days, then differentiated towards pancreatic endoderm. Quantification of Pdx1 expression on
days 8, 10, 12 and 14. Data represented as mean±s.e.m. (B) Immunofluorescence (IF) analysis of pancreatic progenitors derived from Nodal- or
Activin-induced endoderm. White arrow, PDXlow; yellow arrow, PDXhigh. Boxed regions are magnified in insets. (C) FACS characterization of
pancreatic progenitors derived from Activin- or Nodal-induced Pdx1-GFP mESCs. R3, total GFP(+) cells; R4, GFPhigh cells. (D) Histogram showing
quantification of FACS of Pdx1-GFP(+) populations from Activin- and Nodal-induced endoderm. Data represented as mean±s.e.m. (E) Depiction of
kidney capsule injection of ES-derived pancreatic endoderm. (F). IF analysis of sections of transplants derived from PDXhigh and PDXlow injections. C-
peptide marks  cells. (G) Quantification of C-peptide(+) cells in grafts 4-6 weeks after transplantation of equal numbers of PDXhigh and PDXlow
cells. Data represented as mean±s.e.m.
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4-6 weeks of incubation in the kidney capsule, the transplants were
removed, sectioned and stained for markers of mature pancreatic
cells. Particularly, we looked for β cells and the expression of C-
peptide. C-peptide(+) cells were detected in transplants derived from
both PDXhigh and PDXlow populations (Fig. 5F). However,
transplants derived from injections of PDXhigh cells showed a higher
content of β cells, as estimated by the percentage of C-peptide(+)
cells per graft: 43% for PDXhigh transplants, in contrast to 9% for
PDXlow (Fig. 5G; n=6 per group). Moreover, in PDXhigh grafts, the
C-peptide(+) cells were grouped together as 20- to 50-cell islet-like
clusters whereas the PDXlow the clusters were often scattered, or, at
best, arranged in small groups of five to ten cells. We note that, once
sorted into PDXhigh and PDXlow populations, Nodal- and Activin-
derived pancreatic progenitors behaved similarly. As endoderm
derived from Nodal treatment leads to a greater percentage PDXhigh
cells, and PDXhigh cells differentiate more efficiently to C-peptide-
expressing cells, these findings together suggest that Nodal signaling
is more instructive than Activin A in directing endoderm and
pancreatic β cell differentiation in vitro.
DISCUSSION
Directed differentiation of pancreatic β cells from pluripotent stem
cells offers tremendous promise for both disease modeling and cell
therapy. Although significant progress has been made in the
derivation of β-like cells from ES (D’Amour et al., 2006; Jiang et
al., 2007; Kroon et al., 2008; Micallef et al., 2012; Nostro et al.,
2011; Zhang et al., 2009) and iPS (Maehr et al., 2009; Park et al.,
2008) cells, our understanding of the necessary signals required for
the complete derivation of mature β cells in vitro is still limited
(Naujok et al., 2011). To gain insight into the identity of cells born
from in vitro differentiation, we evaluated the in vivo functional
capacity of ES-derived cells at the DE and pancreatic progenitor
stages. We present evidence here that, despite exhibiting highly
similar transcriptional profiles marked by expression of cardinal
endoderm genes, Nodal- and Activin-induced cells are functionally
distinct in their potential for endoderm, pancreatic and β cell
development.
As a functional assay for endoderm, we transplanted mouse
ES-derived endoderm cells into the endoderm compartment of
the mouse embryo to test their ability to identify and interact
with endogenous endoderm. In contrast to Activin-derived
endoderm, Nodal-derived endoderm more efficiently contributes
to embryonic gut tube morphogenesis in vivo, as well as
subsequent differentiation into organ domains, including the
lung, liver, pancreas and intestine. Furthermore, Nodal- but not
Activin-derived endoderm can autonomously generate primitive
gut-tubules upon ectopic injection into mesoderm or ectoderm
compartments, such as the trunk mesenchyme and neural tube,
respectively. In extended experiments using human ES cell-
derived endoderm, we also consistently observed the
autonomous formation of tubular structures of 50-75 m in
length by Nodal- but not Activin-differentiated cultures upon
injection into the same ectopic sites (supplementary material Fig.
S3), suggesting that these differences are conserved between
mouse and human ES cells. The finding that two populations of
ES-derived endoderm that appear nearly identical in vitro behave
strikingly differently in vivo highlights the notion that the
expression of signature genes for a given cell type cannot be
assumed to be coupled to functional competency.
Closer examination of gene-profiling results suggested that this
functional discrepancy might due to a difference in endoderm
progression, with Activin-derived endoderm more closely
resembling mesendoderm or nascent endoderm, whereas Nodal-
derived endoderm resembles advanced endoderm poised for gut
tube morphogenesis and organ-specific differentiation. Upon
continued in vitro differentiation towards pancreatic progenitors,
we found that Nodal-induced endoderm initiates Pdx1 expression
two days earlier than does Activin-induced endoderm, indicating
an inherent difference in cellular readiness or ability to respond to
pancreatic-inducing cues.
The presence of PDXhigh/low cells indicated that, like pancreatic
development in the embryo, pancreatic induction in vitro also
results in cells expressing variable levels of Pdx1. Here, we found
that endoderm derived from Nodal treatment gave rise to 4.6-fold
more PDXhigh cells than endoderm derived from Activin A
treatment. When PDXhigh and PDXlow cells were purified and
injected into mice, we observed in turn, a sixfold greater efficiency
of PDXhigh cells to generate C-peptide(+) cells. These cells were
reminiscent of similar populations of PDXhigh/low cells described
during mouse pancreatic development in vivo (Fujitani et al., 2006;
Nelson et al., 2007; Ohlsson et al., 1993). The first Neurog3(+)
cells at E10.5 and insulin(+) cells at E12.5 are those expressing
high levels of Pdx1, suggesting that the earliest endocrine
progenitors and β cells express high levels of Pdx1 (Nelson et al.,
2007; Nishimura et al., 2006; Ohlsson et al., 1993). Furthermore,
specific depletion of PDXhigh cells by targeted deletion of the Pdx1
cis-regulatory regions (Area I-II-III) leads to highly defective
endocrine development, particularly a failure in β-cell
differentiation (Fujitani et al., 2006).
Existing functional assays for pancreatic differentiation
interrogate only the final target, the β cell. These read-outs include
in vitro quantification of insulin release in response to glucose
stimulation, as well as in vivo rescue of diabetic mouse models
upon transplantation of differentiated cells. Despite significant
progress in the differentiation of mouse and human ES cells into
pancreatic progeny, published protocols have yielded populations
of functionally restricted insulin-producing cells akin to immature
cells of the fetal pancreas. These cells exhibit a polyhormonal
phenotype, lack appropriate glucose responsiveness, or are
contaminated with either off-target cell types or ES cells. Here, we
present a functional assay that targets the first stage of
differentiation into DE. Although it is possible that current
protocols sufficiently drive differentiation and maturation to the
endocrine but not final β cell stage, our work suggests that
functional immaturity already exists at the first stage of endoderm
specification in Activin-driven protocols.
Our findings suggest a model in which both Activin and Nodal
can generate endoderm and pancreatic cell types in vitro, but the
efficiency and quality of the resulting cells are not equal. It is
possible that endoderm requires maturation prior to organogenesis;
perhaps Activin A is able to guide ES cells to an endoderm fate but
they remain immature, whereas Nodal can push them further such
that they become competent to undergo morphogenesis and organ
specification. This is a formal possibility given that Nodal is
expressed and required during mouse endoderm development
whereas Activin A is not. Although Nodal induces Smad2/3
phosphorylation via the same TypeI/TypeII TGFβ receptors that
Activin A employs, a crucial difference is the obligate presence of
the co-receptor Cripto. It therefore remains to be defined whether
Cripto confers an additional level of specificity on Smad-dependent
signaling and/or conveys Smad-independent effects (Semb, 2008).
The findings presented here suggest that Nodal might be the more
developmentally relevant molecule for ES cell differentiation into
functional endoderm derivatives.
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From a global perspective, our observations emphasize the need
for more stringent standards in ES cell differentiation and
evaluation. Although gene expression analysis is crucial in the
initial characterization of ES cell-derived cell types, it is not
sufficient. Microarray technology has become highly valuable for
identifying complex global changes in gene expression patterns.
However, the information obtained by expression profiling is
simply the amount of each mRNA species present. Even when we
looked beyond the global similarity of Nodal- versus Activin-
induced endoderm, we found only a modest difference in a small
set of genes, suggestive of a difference in cell states. As cellular
processes, including differentiation, are ultimately controlled at the
level of the protein, even the same pool of transcripts could lead to
variable output of active, properly localized proteins (Lu et al.,
2009). All of these factors could result in significant differences in
cellular identity and behavior that are not recognizable at the level
of the transcriptome and in the absence of rigorous functional
assays.
A better understanding of the molecular state of in vitro-derived
cells is only one of multiple aspects that should be considered when
striving for optimal differentiation parameters. In the embryo,
pancreas organogenesis a multi-tissue-directed process in which
evolving interactions occur between epithelia, mesenchyme and
endothelial cells. It is therefore likely that generation of fully
differentiated β cells will require co-culture with pancreatic
mesenchyme (Sneddon et al., 2012), endothelial cells, or their
purified derivatives. Three-dimensional culture environments may
also facilitate this process and ultimately aid in the development,
maturation and function of in vitro-differentiated β cells. Together,
these strategies will provide a grounded basis for continued
progress in the derivation of insulin-producing cells for disease
research and regenerative biology.
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